Ally Bridge Group is a global healthcare-focused investment firm with offices in Hong Kong and New York. The firm backs pioneering life sciences companies with a multi-stage strategy spanning venture capital, growth equity, public market funds, and buyouts.
Ally Bridge uses its global reach to connect transformative healthcare technologies with international markets, addressing major unmet medical needs. The firm has achieved more than 50 exits and invested across oncology, rare diseases, diagnostics, and medical devices.
Founded in 2013, Ally Bridge Group combines deep scientific expertise with financial acumen, providing portfolio companies with regulatory guidance, clinical development support, and access to both Asian and Western healthcare markets.
Hong Kong & New York
"Pioneering life sciences investing — 50+ exits, connecting transformative healthcare technologies between Asia and Western markets."
Apply to the Apex Startup Discovery Program
Aligned with Ally Bridge Group's investment focus. Precondition: You must be an Apex Participant to submit.
Apex Ecosystem with Golden Ads
"Who I Am · What I Want" — Complimentary at myapex.me — includes 2 Golden Ads.
Become an Apex Participant →